Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Clairton › NPI 1578560504
Hospital

Jefferson Regional Medical Center

Jefferson Regional Medical Center was paid $12.73M by Medicaid between Jan 2018 and Dec 2024, across 253 billing codes. Its largest line is G0378, Hospital observation service, per hour — 28% of everything it billed.

33Billing provider infoJEFFERSON REGIONAL MEDICAL CENTER
CLAIRTON, PA 15025
33aNPI1578560504assigned 07/06/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$12.73M
24GClaims384,912
24DCodes billed253
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#25 of 154
Median peer was paid$2.82M
This provider vs. median4.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201855$3K
2019311$8K
202035,108$841K
2021170,153$4.50M
202267,090$2.44M
202364,132$2.70M
2024incomplete48,063$2.24M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G0378 Hospital observation service, per hour 28% 4,027 3,793 $3.52M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 23% 20,448 19,756 $2.99M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 13% 12,148 11,923 $1.65M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 11% 12,165 11,966 $1.41M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.9% 3,129 3,078 $371K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 1.7% 11,866 11,265 $213K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 1.6% 2,538 2,503 $208K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 1.2% 2,341 2,317 $154K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 1.2% 3,095 1,408 $148K
80053 Comprehensive metabolic panel 1.1% 18,203 16,699 $134K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 29,952 26,988 $107K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 15,499 14,715 $97K
241 more codes
70450 Computed tomography, head or brain; without contrast material <1% 2,146 $85K
96375 Therapeutic injection; each additional sequential IV push <1% 6,804 $69K
84484 <1% 9,220 $66K
71275 Computed tomographic angiography, chest, with contrast material <1% 577 $62K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 1,521 $61K
80048 Basic metabolic panel (calcium, ionized) <1% 11,493 $58K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 993 $55K
80050 General health panel <1% 1,184 $45K
84443 Thyroid stimulating hormone (TSH) <1% 2,202 $39K
71046 Radiologic examination, chest; 2 views <1% 3,669 $39K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 473 $37K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 652 $37K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 312 $36K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 497 $33K
96361 Intravenous infusion, hydration; each additional hour <1% 3,544 $33K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 392 $32K
80061 Lipid panel <1% 2,507 $32K
71045 Radiologic examination, chest; single view <1% 5,885 $28K
77067 Screening mammography, bilateral, including computer-aided detection <1% 317 $24K
87806 <1% 1,110 $23K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 304 $23K
83690 <1% 7,343 $22K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 535 $22K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 169 $21K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 649 $20K
86803 <1% 1,319 $20K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 810 $19K
72125 Computed tomography, cervical spine; without contrast material <1% 409 $18K
70496 <1% 192 $18K
81025 <1% 6,720 $18K
0002A <1% 403 $18K
70498 <1% 197 $18K
0001A <1% 419 $17K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 1,331 $16K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 740 $15K
80299 <1% 665 $14K
70551 Magnetic resonance imaging, brain; without contrast material <1% 119 $14K
83735 <1% 3,370 $12K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 305 $12K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 168 $12K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 52 $12K
47562 <1% 13 $11K
71250 <1% 220 $11K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 154 $11K
81001 <1% 6,087 $11K
93971 <1% 222 $11K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 295 $10K
85027 <1% 1,724 $10K
83036 Hemoglobin; glycosylated (A1C) <1% 1,693 $10K
84702 <1% 616 $9K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 348 $9K
76830 Ultrasound, transvaginal <1% 252 $9K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 41 $9K
82607 <1% 694 $8K
86780 <1% 506 $8K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,261 $8K
72141 <1% 42 $7K
93970 <1% 128 $7K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 455 $7K
88342 <1% 353 $7K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 156 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,444 $7K
0100U <1% 185 $7K
85379 <1% 1,052 $7K
82728 <1% 629 $7K
84439 <1% 845 $6K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 211 $6K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 764 $6K
77063 Screening digital breast tomosynthesis, bilateral <1% 297 $6K
80076 <1% 1,000 $6K
76801 <1% 172 $6K
81003 <1% 2,675 $5K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 679 $5K
70486 <1% 97 $5K
87040 <1% 551 $5K
83880 <1% 421 $5K
76536 <1% 108 $5K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 350 $5K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 31 $5K
87340 <1% 295 $4K
84153 <1% 167 $4K
73610 <1% 329 $4K
83605 <1% 1,256 $4K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 165 $4K
86850 <1% 791 $4K
97162 <1% 594 $4K
83970 <1% 96 $4K
76642 <1% 92 $4K
85610 <1% 1,777 $4K
96376 <1% 2,111 $4K
84999 <1% 1,139 $4K
83540 <1% 494 $4K
87077 <1% 623 $4K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 13 $3K
93017 <1% 190 $3K
73630 <1% 407 $3K
82570 <1% 487 $3K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 547 $3K
73564 <1% 219 $3K
73130 <1% 307 $3K
36415 Collection of venous blood by venipuncture <1% 8,918 $3K
86762 <1% 138 $3K
73030 <1% 258 $3K
85730 <1% 981 $3K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 71 $3K
J3490 Unclassified drugs <1% 3,644 $3K
82043 <1% 362 $3K
82746 <1% 288 $3K
72100 <1% 167 $3K
86787 <1% 132 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 11,766 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 523 $3K
87522 Neg quan hep c or qual rna <1% 75 $2K
82805 <1% 209 $2K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 21 $2K
87186 <1% 456 $2K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 284 $2K
86900 <1% 876 $2K
J2785 Injection, regadenoson, 0.1 mg <1% 78 $2K
86901 <1% 858 $2K
86038 <1% 129 $2K
77065 Tomosynthesis, mammo <1% 32 $2K
87081 <1% 413 $2K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 30 $2K
97161 <1% 52 $2K
87075 <1% 233 $2K
90715 <1% 277 $2K
83550 <1% 390 $2K
87631 <1% 18 $2K
73502 <1% 137 $2K
72131 <1% 36 $2K
82565 <1% 351 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 330 $1K
85652 <1% 569 $1K
82784 <1% 66 $1K
94729 <1% 63 $1K
84100 <1% 402 $1K
12001 <1% 25 $1K
86140 <1% 522 $1K
87802 <1% 115 $1K
82962 <1% 2,108 $1K
73110 <1% 141 $1K
82248 <1% 177 $1K
97164 <1% 38 $1K
80320 <1% 136 $1K
87070 <1% 261 $1K
86618 <1% 48 $1K
94726 <1% 49 $1K
84550 <1% 204 $992.47
0003A <1% 38 $992.00
82550 <1% 238 $937.72
84466 <1% 55 $927.58
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 31 $921.11
88313 <1% 41 $847.90
87205 <1% 304 $836.77
83615 <1% 153 $783.25
86706 <1% 48 $684.30
87481 <1% 16 $682.25
82950 <1% 92 $678.15
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 14 $676.40
72040 <1% 42 $597.16
97166 <1% 319 $587.63
73560 <1% 56 $571.89
80329 <1% 98 $568.20
74018 <1% 63 $536.77
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,643 $495.01
86592 <1% 123 $492.05
J2704 Injection, propofol, 10 mg <1% 3,362 $474.46
80074 <1% 12 $458.42
J1815 Injection, insulin, per 5 units <1% 826 $450.97
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 82 $447.70
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 18 $398.45
84703 <1% 50 $395.86
84156 <1% 94 $354.67
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,134 $350.65
84481 <1% 12 $332.97
J7120 Ringers lactate infusion, up to 1000 cc <1% 3,658 $300.17
87486 <1% 13 $297.88
80069 <1% 42 $295.93
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 413 $245.68
82947 <1% 73 $234.50
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 104 $233.29
86255 <1% 12 $231.76
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 134 $227.37
82105 <1% 13 $225.70
J3475 Injection, magnesium sulfate, per 500 mg <1% 573 $215.96
82977 <1% 28 $213.87
93320 <1% 12 $204.68
84145 <1% 60 $203.10
J0780 Injection, prochlorperazine, up to 10 mg <1% 549 $200.30
93325 <1% 12 $183.22
84460 <1% 26 $180.75
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 340 $172.64
C9113 Injection, pantoprazole sodium, per vial <1% 969 $158.66
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,319 $155.90
84450 <1% 25 $151.08
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 6,952 $140.76
76937 <1% 29 $130.54
J1170 Injection, hydromorphone, up to 4 mg <1% 655 $128.81
88304 <1% 125 $127.08
86430 <1% 14 $117.42
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,619 $108.30
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 2,301 $100.60
83516 <1% 32 $99.85
94060 <1% 14 $97.35
95819 <1% 16 $96.66
82553 <1% 13 $93.20
J3370 Injection, vancomycin hcl, 500 mg <1% 328 $92.28
J1650 Injection, enoxaparin sodium, 10 mg <1% 434 $83.82
J0690 Injection, cefazolin sodium, 500 mg <1% 1,612 $76.32
86308 <1% 12 $70.14
J1644 Injection, heparin sodium, per 1000 units <1% 2,100 $67.67
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,576 $63.26
82140 <1% 18 $47.00
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 799 $44.84
J2060 Injection, lorazepam, 2 mg <1% 410 $41.51
J3480 Injection, potassium chloride, per 2 meq <1% 149 $34.13
94760 <1% 82 $32.39
C1769 Guide wire <1% 87 $29.01
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 315 $28.79
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,545 $22.35
81002 <1% 12 $21.59
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 59 $21.07
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 296 $19.27
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 54 $18.03
S0030 Injection, metronidazole, 500 mg <1% 192 $12.12
J7999 Compounded drug, not otherwise classified <1% 319 $10.94
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 213 $9.36
J7060 5% dextrose/water (500 ml = 1 unit) <1% 84 $7.78
A9270 Non-covered item or service <1% 34,101 $7.58
J7050 Infusion, normal saline solution, 250 cc <1% 132 $6.25
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 2,598 $5.91
94761 <1% 14 $5.33
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 123 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 3,189 $0.00
J0295 Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm 0% 133 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 68 $0.00
97116 0% 18 $0.00
J0330 Injection, succinylcholine chloride, up to 20 mg 0% 241 $0.00
J1940 Injection, furosemide, up to 20 mg 0% 16 $0.00
99153 Mod sedat endo service >5yrs 0% 19 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFRIES, RICK (VP FINANCE)
Same official

Other billing entities under FRIES, RICK

Full network →
ProviderLocationPaid
West Penn Allegheny Health System INCPittsburgh, PA$12.69M
West Penn Allegheny Health System INC.Pittsburgh, PA$10.81M
West Penn Allegheny Health System INC.Monroeville, PA$8.24M
Alle-Kiski Medical CenterNatrona Heights, PA$6.09M
Canonsburg General HospitalCanonsburg, PA$2.97M
Grove City Medical CenterGrove City, PA$2.17M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.